Fractionation and late rectal toxicity: No reliable estimates of α/β value for rectum can be derived from studies where different volumes of rectum are irradiated at different dose levels: In regard to Brenner [1] (multiple letters)

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 1, 2005, Pages 289-290

  Fiorino, Claudio ^a   Sanguineti, Giuseppe ^b   Valdagni, Riccardo ^c   Brenner, David J ^d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b University of Texas Medical Branch School of Medicine   (United States)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRACTIONATION; HUMAN; LETTER; PREVALENCE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RECTUM INJURY; RISK ASSESSMENT;

EID: 17844401464     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.01.015     Document Type: Letter

References (17)

1. D.J. Brenner Fractionation and late rectal toxicity Int J Radiat Oncol Biol Phys 60 2004 1013 1015
2. M.W. Skwarchuk A. Jackson M.J. Zelefsky Late rectal toxicity after conformal radiotherapy of prostate cancer (I) Multivariate analysis and dose-response Int J Radiat Oncol Biol Phys 47 2000 103 113
3. M.J. Zelefsky D. Cowen Z. Fuks Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma Cancer 85 1999 2460 2468
4. J.M. Michalsky K. Winter J.A. Pudry Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II Int J Radiat Oncol Biol Phys 56 2003 192 198
5. D. Kuban A. Pollack E. Huang Hazards of dose escalation in prostate cancer radiotherapy Int J Radiat Oncol Biol Phys 57 2003 1260 1268
6. T. Akimoto H. Muramashi M. Taahashi Rectal bleeding after hypofractionated radiotherapy for prostate cancer Correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding Int J Radiat Oncol Biol Phys 60 2004 1033 1039
7. M.R. Storey A. Pollack G. Zagars Complications from radiotherapy dose escalation in prostate cancer Preliminary results of a randomized trial Int J Radiat Oncol Biol Phys 48 2000 635 642
8. L.J. Boersma M. van den Brink A.M. Bruce Estimation of the incidence of late bladder and rectum complications after high-dose (70–78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms Int J Radiat Oncol Biol Phys 41 1998 83 92
9. C. Fiorino G. Sanguineti C. Cozzarini Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer Int J Radiat Oncol Biol Phys 57 2003 953 962
10. C. Fiorino C. Cozzarini V. Vavassori Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer Analysis of a large group of patients pooled from three institutions Radiother Oncol 64 2002 1 12
11. E.H. Huang A. Pollack L. Levy Late rectal toxicity Dose-volume effects of conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 54 2002 1314 1321
12. T. Rancati C. Fiorino G. Gagliardi Fitting late rectal bleeding data using different NTCP models Results from an Italian multi-centric study (AIROPROS0101) Radiother Oncol 73 2004 21 32
13. A. Zapatero F. Garcia-Valente I. Modolell Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer Dose-volume effect Int J Radiat Oncol Biol Phys 59 2004 1343 1351
14. G. Bauman G. Rodrigues Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer Int J Radiat Oncol Biol Phys 59 2004 912 913 In regard to Fiorino, et al
15. P.A. Kupelian C.A. Reddy T.P. Carlson Dose-volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer Absolute or relative rectal volume? Cancer J 8 2002 62 66
16. W. Dorr J.H. Hendry Consequential late effects in normal tissues Radioth Oncol 61 2001 223 231
17. P.C. O’Brien C.I. Franklin M.G. Poulsen Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis Longer term follow-up of a phase III trial—Trans-Tasman Radiation Oncology Group Int J Radiat Oncol Biol Phys 54 2002 442 449